From basic research to clinical development of MEK1/2 inhibitors for cancer therapy.
J Hematol Oncol. 2010 Feb 11;3:8. doi: 10.1186/1756-8722-3-8.
J Hematol Oncol. 2010.
PMID: 20149254
Free PMC article.
Review.